Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance.

Harold E Bays,LeAnne T Bloedon,Grace Lin,Heather A Powell,Michael J Louie,Stephen J Nicholls,A Michael Lincoff,Steven Nissen

Journal of clinical lipidology（2023）

引用 0|浏览5

暂无评分

摘要

Bempedoic acid was well-tolerated compared with placebo. Safety data from the long-term CLEAR Outcomes study reinforce the positive benefit-risk profile of bempedoic acid.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要